ZSQ836 is an orally active dual covalent inhibitor of CDK12/CDK13 , with an EC 50 value of 32 nM against CDK12 . ZSQ836 can induce apoptosis and exhibit anticancer activity in vivo . ZSQ836 can be used in the study of ovarian cancer .
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > CDK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.